InsiderTrades

Form 4 for ALT Altimmune, Inc.

Accepted 2023-02-06 00:00:00 ET · period of report 2023-02-02 · accession 0001104659-23-011214 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-02-06 2023-02-02 ALT Roberts M Scot CSO F - Tax $15.04 -2,375 19.9K -11% -$35.7K
D 2023-02-06 2023-02-02 ALT Roberts M Scot CSO M - OptEx $0.00 +7,775 22.2K +54% $0
D 2023-02-06 2023-02-02 ALT Roberts M Scot CSO M - OptEx $0.00 -7,775 23.3K -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, par value $0.0001 2023-02-02 F D 2,375 $15.04 19,856 D — —
2 Common Common Stock, par value $0.0001 2023-02-02 M A 7,775 $0.00 22,231 D — — (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested.
3 Derivative Restricted Stock Units 2023-02-02 M D 7,775 $0.00 23,325 D — · — to — 7,775 Common Stock, par value $0.0001 (F1) Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Common Stock, par value $0.0001, when vested. (F3) The RSUs become vested in substantially equal annual installments over the 4 years following February 2, 2022, subject to the reporting person's continued service through the applicable vesting date, and have no expiration date.